SELLAS Life Sciences Group, Inc.

NasdaqCM:SLS Stock Report

Market Cap: US$71.6m

SELLAS Life Sciences Group Dividend

Dividend criteria checks 0/6

SELLAS Life Sciences Group does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.65
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To Spend Its Cash Wisely

Jul 13
SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To Spend Its Cash Wisely

SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To Spend Its Cash Wisely

Sep 20
SELLAS Life Sciences Group (NASDAQ:SLS) Will Have To Spend Its Cash Wisely

SELLAS Life Sciences rises 9% after cancer drug shows promising result in animal study

Aug 09

We Think SELLAS Life Sciences Group (NASDAQ:SLS) Needs To Drive Business Growth Carefully

Mar 08
We Think SELLAS Life Sciences Group (NASDAQ:SLS) Needs To Drive Business Growth Carefully

Is SELLAS Life Sciences Group (NASDAQ:SLS) In A Good Position To Invest In Growth?

Nov 23
Is SELLAS Life Sciences Group (NASDAQ:SLS) In A Good Position To Invest In Growth?

Companies Like SELLAS Life Sciences Group (NASDAQ:SLS) Are In A Position To Invest In Growth

Jul 19
Companies Like SELLAS Life Sciences Group (NASDAQ:SLS) Are In A Position To Invest In Growth

SELLAS Life Sciences updates on at-the-market offering

Jun 02

SELLAS Life Sciences jumps 43% after Reddit mentions

Feb 03

Sellas' galinpepimut-S combo shows promising action in early-stage solid tumor studies

Dec 21

Sellas Life Sciences strengthens balance sheet with addition of $30.5M

Dec 17

Sellas Life Sciences prices $16.2M direct offering

Dec 14

Nelipepimut-S data from breast cancer study fails to lift SELLAS Life Sciences

Dec 11

SELLAS and 3D Medicines in exclusive license agreement for development and commercialization of GPS and GPS+ in Greater China

Dec 07

SELLAS Life Sciences EPS misses by $0.26

Nov 13

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if SLS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SLS's dividend payments have been increasing.


Dividend Yield vs Market

SELLAS Life Sciences Group Dividend Yield vs Market
How does SLS dividend yield compare to the market?
SegmentDividend Yield
Company (SLS)n/a
Market Bottom 25% (US)1.6%
Market Top 25% (US)4.8%
Industry Average (Biotechs)2.9%
Analyst forecast in 3 Years (SLS)n/a

Notable Dividend: Unable to evaluate SLS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SLS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate SLS's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as SLS has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.